REGN vs SIF · P/E 14, rev $14.34B vs rev $21.7M
Regeneron Pharmaceuticals Inc (REGN) versus SIFCO Industries Inc (SIF) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
SIFCO Industries Inc (SIF) is a aerospace & defense company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SIF revenue for 2024-09-30 was $21.7M. Net income was -$443.0K. Revenue was down 1.5% from 2024-06-30 to 2024-09-30. SIF currently screens at market cap $25.0M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SIF currently screens at market cap $25.0M.
Not investment advice. Open the REGN and SIF stock pages for the full models.
Not investment advice.